Enzo Biochem Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (40)

View All

Latest Posts

About This Stock More About This Stock
Enzo Biochem: Genetics And Diagnostics
Article By: MoneyShow.com
Thursday, November 1, 2018 5:00 AM EDT
This NYSE-listed stock was selling for more than $12 just 14 months ago. Now that it has fallen 70%, we think it’s a good time to accumulate shares.
In this article: ENZ
Read
Bayer (BAYRY) Q2 Earnings Beat, Sales Miss, Cuts Guidance
Article By: Zacks Investment Research
Thursday, July 27, 2017 10:00 AM EDT
Bayer AG’s second-quarter 2017 core earnings per share from continuing operations was $1.99. Earnings were down 12.7% year over year from $2.28 per share.
In this article: ENZ, MON, SNY, BAYRY
Read
5 Stocks With Recent Price Strength To Enhance Your Returns
Article By: Zacks Investment Research
Thursday, July 13, 2017 1:07 PM EDT
Every investor wishes to have a magical portfolio of stocks with a one way ticket to success. But this is easier said than done. And when the market is as volatile as it is now, things may take a turn for the worse any moment.
In this article: BID, ENZ, FSS, MOD, CVGI
Read
5 Biomedical Stocks That Are Expected To Surge
Article By: Zacks Investment Research
Tuesday, June 27, 2017 5:01 PM EDT
Every investor struggles with balancing risk and reward when choosing their investments. Biomedical companies are known to offer large capital gains and growth prospects, yet they do not always come to fruition.
In this article: GERN, REGN, KDMN, ENZ, AVXL Also: JNJ
Read
Is The S&P 500 The Right Portfolio For You?
Article By: Joseph Shaefer
Sunday, April 2, 2017 8:55 PM EDT
The USA is the world’s biggest economy. Is the most popular index, the S&P 500, enough to give you the best of all possible outcomes? Take a look at these charts and decide what is best for you.
In this article: CHK, ENZ, HPQ, HQL, MXE, RRC, SWN, RHHBY, PRFRX, CERN, CSCO, DBEU, DOC, LADR, QLEIX, VARAX, FPE
Read
All Posts

Latest Tweets for $ENZ

No tweets yet!

PARTNER HEADLINES